Lonsurf - RII Lonsurf (TAS-102) with or without bevacizumab in patients with chemo-refractory metastatic colorectal cancer.
Phase of Trial: Phase II
Latest Information Update: 19 Jan 2019
At a glance
- Drugs Tipiracil/trifluridine (Primary) ; Bevacizumab
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- 19 Jan 2019 Results (n=80) presented at the 2019 Gastrointestinal Cancers Symposium.
- 08 Aug 2018 Planned number of patients changed from 80 to 124.
- 27 Apr 2017 New trial record